These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11214755)
21. Alterations in mucus barrier function and matrix structure induced by guluronate oligomers. Nordgård CT; Nonstad U; Olderøy MØ; Espevik T; Draget KI Biomacromolecules; 2014 Jun; 15(6):2294-300. PubMed ID: 24827030 [TBL] [Abstract][Full Text] [Related]
22. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. Maisel K; Reddy M; Xu Q; Chattopadhyay S; Cone R; Ensign LM; Hanes J Nanomedicine (Lond); 2016 Jun; 11(11):1337-43. PubMed ID: 27171816 [TBL] [Abstract][Full Text] [Related]
29. Thiomers: a new generation of mucoadhesive polymers. Bernkop-Schnürch A Adv Drug Deliv Rev; 2005 Nov; 57(11):1569-82. PubMed ID: 16176846 [TBL] [Abstract][Full Text] [Related]
30. Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies. Sperandio B; Fischer N; Sansonetti PJ Semin Immunol; 2015 Mar; 27(2):111-8. PubMed ID: 25936225 [TBL] [Abstract][Full Text] [Related]
31. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Teubl BJ; Absenger M; Fröhlich E; Leitinger G; Zimmer A; Roblegg E Eur J Pharm Biopharm; 2013 Jun; 84(2):386-93. PubMed ID: 23291061 [TBL] [Abstract][Full Text] [Related]
32. Reinforcing Mucus Barrier Properties with Low Molar Mass Chitosans. Kootala S; Filho L; Srivastava V; Linderberg V; Moussa A; David L; Trombotto S; Crouzier T Biomacromolecules; 2018 Mar; 19(3):872-882. PubMed ID: 29451983 [TBL] [Abstract][Full Text] [Related]
33. The Amount of MUC5B mucin in cervical mucus peaks at midcycle. Gipson IK; Moccia R; Spurr-Michaud S; Argüeso P; Gargiulo AR; Hill JA; Offner GD; Keutmann HT J Clin Endocrinol Metab; 2001 Feb; 86(2):594-600. PubMed ID: 11158014 [TBL] [Abstract][Full Text] [Related]
34. Antibody diffusion in human cervical mucus. Saltzman WM; Radomsky ML; Whaley KJ; Cone RA Biophys J; 1994 Feb; 66(2 Pt 1):508-15. PubMed ID: 8161703 [TBL] [Abstract][Full Text] [Related]
36. Mucus and H. pylori. Allen A; Newton J; Oliver L; Jordan N; Strugala V; Pearson JP; Dettmar PW J Physiol Pharmacol; 1997 Sep; 48(3):297-305. PubMed ID: 9376612 [TBL] [Abstract][Full Text] [Related]
37. Mucoadhesive functionality of cell wall structures from fruits and grains: Electrostatic and polymer network interactions mediated by soluble dietary polysaccharides. Meldrum OW; Yakubov GE; Gartaula G; McGuckin MA; Gidley MJ Sci Rep; 2017 Nov; 7(1):15794. PubMed ID: 29150632 [TBL] [Abstract][Full Text] [Related]
38. Lipids alter microbial transport through intestinal mucus. Carlson TL; Yildiz H; Dar Z; Lock JY; Carrier RL PLoS One; 2018; 13(12):e0209151. PubMed ID: 30576356 [TBL] [Abstract][Full Text] [Related]
39. Variances in mucus architecture as a cause of cervical factor infertility. Poon WW; McCoshen JA Fertil Steril; 1985 Sep; 44(3):361-5. PubMed ID: 4029424 [TBL] [Abstract][Full Text] [Related]
40. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it? Pearson JP; Chater PI; Wilcox MD Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]